Polycythemia vera
Jump to navigation
Jump to search

Clinical criteria
JAK2 mutations
Mutations in the JAK2 gene, specifically at the V617F locus, give rise to myeloproliferative disorders such as essential thrombocythemia and polycythemia vera.[1]
Authors reported[2] that other mutations of the coding region of the JAK2 gene could create a polycythemia phenotype.